Rafael Holdings, Inc. Class B Common Stock RFL
Key Stats
- Today's Range
- $2.39 – $2.64
- 50-Day Range
- $1.77 – $3.96
- 52-Week Range
- $1.12 – $3.96
- Volume
- 77K shs
- Average Volume
- 103K shs
- Market Cap
- $130.52 million
- P/E Ratio
- —
- Dividend Yield
- 3.27%
Valuation
- P/E Ratio
- —
- Price / Book
- 1.62
- Price / Sales
- 133.18
Dividend
- Dividend Yield
- 3.27%
- Annual Dividend
- $0.08
- Payout Ratio
- —
- Ex-Dividend Date
- 2009-12-18
Short Interest
- Short Interest
- 2.78%
- Days to Cover
- 7.19
Financials (TTM)
- Revenue
- $980,000
- Net Income
- $-19,312,000
- Net Margin
- -1970.61%
- Return on Equity
- -23.90%
- Debt-to-Equity
- —
About Rafael Holdings, Inc. Class B Common Stock
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Related Stocks
Compare head-to-head: RFL vs LLY·RFL vs JNJ·RFL vs ABBV·RFL vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.